Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zenzaburo Nakata

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|January 6, 2011
Crystallization and preliminary crystallographic analysis of human LR11 Vps10p domainZenzaburo Nakata, Masamichi Nagae, Norihisa Yasui, et al.
Journal of Medicinal Chemistry|July 1, 2024
Discovery and Hit to Lead Optimization of Macrocyclic Peptides as Novel Tropomyosin Receptor Kinase A AntagonistsToru Yamada, Kousuke Mihara, Taichi Ueda, et al.
Nature Structural & Molecular Biology|February 3, 2015
Structural basis for amyloidogenic peptide recognition by sorLAYu Kitago, Masamichi Nagae, Zenzaburo Nakata, et al.
Journal of Medicinal Chemistry|April 13, 2022
Pocket-to-Lead: Structure-Based <i>De Novo</i> Design of Novel Non-peptidic HIV-1 Protease Inhibitors Using the Ligand Binding Pocket as a TemplateEiichi Kojima, Atsuhiro Iimuro, Mado Nakajima, et al.
ACS Medicinal Chemistry Letters|October 20, 2022
Highly Potent and Oral Macrocyclic Peptides as a HIV-1 Protease Inhibitor: mRNA Display-Derived Hit-to-Lead OptimizationYoshifumi Kusumoto, Kyohei Hayashi, Soichiro Sato, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|January 6, 2011
Crystallization and preliminary crystallographic analysis of human LR11 Vps10p domainZenzaburo Nakata, Masamichi Nagae, Norihisa Yasui, et al.
Journal of Medicinal Chemistry|July 1, 2024
Discovery and Hit to Lead Optimization of Macrocyclic Peptides as Novel Tropomyosin Receptor Kinase A AntagonistsToru Yamada, Kousuke Mihara, Taichi Ueda, et al.
Nature Structural & Molecular Biology|February 3, 2015
Structural basis for amyloidogenic peptide recognition by sorLAYu Kitago, Masamichi Nagae, Zenzaburo Nakata, et al.
Journal of Medicinal Chemistry|April 13, 2022
Pocket-to-Lead: Structure-Based <i>De Novo</i> Design of Novel Non-peptidic HIV-1 Protease Inhibitors Using the Ligand Binding Pocket as a TemplateEiichi Kojima, Atsuhiro Iimuro, Mado Nakajima, et al.
ACS Medicinal Chemistry Letters|October 20, 2022
Highly Potent and Oral Macrocyclic Peptides as a HIV-1 Protease Inhibitor: mRNA Display-Derived Hit-to-Lead OptimizationYoshifumi Kusumoto, Kyohei Hayashi, Soichiro Sato, et al.
Pageof 1